Showing results (1391-1400 of 1,497) with videos related to
Sort By:
Pageof 150
AIDS (London, England)|April 2, 2019
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trialsSamir K Gupta, Frank A Post, José R Arribas, et al.Nature Methods|May 11, 2010
Coding of facial expressions of pain in the laboratory mouseDale J Langford, Andrea L Bailey, Mona Lisa Chanda, et al.International Archives of Allergy and Immunology|June 26, 2026
Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post StudyJoseph Najem, Alexandre Ton That, Connor Prosty, et al.JPEN. Journal of Parenteral and Enteral Nutrition|February 15, 2021
COVID-19 infection in patients with intestinal failure: UK experienceP J Allan, T Ambrose, C Mountford, et al.Science Advances|April 1, 2021
Processed foods drive intestinal barrier permeability and microvascular diseasesMatthew Snelson, Sih Min Tan, Rachel E Clarke, et al.The Lancet Regional Health. Western Pacific|October 20, 2023
Community-wide versus school-based targeted deworming for soil-transmitted helminth control in school-aged children in Vietnam: the CoDe-STH cluster-randomised controlled trialClare E F Dyer, Dinh Ng-Nguyen, Naomi E Clarke, et al.The Journal of Rheumatology|October 16, 2020
Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus ErythematosusDaniela Dominguez, Sylvia Kamphuis, Joseph Beyene, et al.Journal of Medicinal Chemistry|March 29, 2000
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agentS M Bromidge, S Dabbs, D T Davies, et al.Pain|October 26, 2000
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1Philip Hayes, Helen J Meadows, Martin J Gunthorpe, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 9, 2023
Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry dataLuca Delli Colli, Adnan Al Ali, Sofianne Gabrielli, et al.Pageof 150